The emergence and global impact of COVID-19 has focused the scientific and medical
community on the pivotal influential role of respiratory viruses as causes of severe …

Introduction: Asthma is a chronic inflammatory disease of the airways with a large
heterogeneity of clinical phenotypes. There has been increasing interest regarding the role …

Asthma prevalence in Italy is on the rise and is estimated to be over 6% of the general
population. The diagnosis of asthma can be challenging and elusive, especially in children …

Background and Objectives: Measurement of fractional exhaled nitric oxide (FeNO)
concentration is currently used as a non-invasive biomarker to assess airway inflammation …

Objective The aim of our study was to analyze the montelukast effectiveness in improving
oculonasal symptoms, patient‐reported outcomes (PROs), and eosinophilic biomarkers in …

Montelukast sodium is an effective and well-tolerated anti-asthmatic drug. Long non-coding
RNAs (lncRNAs) are involved in the treatment of asthma. Therefore, this study aimed to …

The relationship between asthma and sleep-disordered breathing is bidirectional due to
common risk factors that promote airway inflammation. Obstructive sleep-disordered …

目的探讨白三烯受体拮抗剂影响Wnt7b, β-catenin 及c-Myc 表达, 干预哮喘小鼠气道重塑机制的
研究. 方法采用卵蛋白(OVA) 致敏和激发建立小鼠哮喘模型. 将小鼠分为对照组 …

Montelukast (MLK), an oral antiasthmatic drug with growing use, requires special care in
formulation and storage to avoid its degradation by action of light and water. This work …

At its introduction in the management of pediatric asthma, montelukast was regarded as a
potentially revolutionary drug due to its mechanism of action and easy clinical applicability …